Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia

Status unconfirmed

Conditions studied: Chronic Migraine, Fibromyalgia, New Daily Persistent Headache

In brief

This research aims to look at the effect of low-dose naltrexone on the severity and frequency of attacks in people with chronic migraine with or without new daily persistent headache and fibromyalgia. A few studies suggest low-dose naltrexone is effective for fibromyalgia, but it has not been studied in patients with migraine and headaches. Our goal is to see if there is an improvement in either severity and frequency of attacks and overall impact on quality of life over a three-month period.

Key facts

Study ID
NCT05536050
Run by
Thomas Jefferson University
People needed
30
Starts
2022-07-28
Expected to finish
2023-12-01
Last updated by the study team
2022-10-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.